Hepagel Liquid (L-Aspartic Acid-L-Ornithine)
L-Ornithine-L-Aspartate 3g
OTC medication
Telcon RF Pharmaceutical Co., Ltd.
MFDS item code 201504728 · Approved 2015.07.09 · Insurance code 625500301
Auxiliary treatment for detoxification in severe liver disease
This medication is used as an auxiliary treatment to assist the detoxification process of the liver in conditions such as severe liver disease. For example, it is prescribed to patients with cirrhosis to improve liver function and support detoxification capabilities. It helps to relieve the burden on the liver and improve the overall health condition of the patient.
As a L-Aspartic Acid-L-Ornithine, take 6 g once, twice a day. Dissolve in plenty of water and take after meals (for powdered form). Take after meals (for liquid form).
This medication should not be taken by individuals with severely impaired kidney function, particularly those with serum creatinine levels above 3 mg/100 mL due to severe renal failure. Before taking this medicine, individuals who have a history of allergy to acetylsalicylic acid or experienced allergic reactions such as asthma should consult a physician or pharmacist. Additionally, this medication contains a dye called Yellow No. 5, so individuals sensitive to this component or with a history of allergies should use it with caution. If any unusual symptoms or side effects appear during use, immediately stop taking the medicine and consult a healthcare professional. If symptoms do not improve after taking the medication for about two weeks, stop taking it and consult a doctor. This medication must be taken strictly according to the prescribed dosage and should not be altered arbitrarily. Store in a safe place out of the reach of children. The medication should be stored away from direct sunlight and in a cool, dry place. Also, do not transfer the medication to another container after removing it from its original container, and always securely close the lid of the original container to maintain the quality of the medicine.
Severe renal failure (increased serum creatinine levels), immediate cessation of use and consultation are necessary if adverse reactions occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. This will help to maintain the effectiveness of the medication and prevent deterioration.
A light brown liquid contained in an aluminum foil pouch
1 pouch (15g) x 30
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Ornithine-L-Aspartate 3g
OTC medication
Telcon RF Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Prescription medication
Hanwha Pharm Co., Ltd.
L-Ornithine-L-Aspartate 3g
OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Daewon Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.